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The global prevalence of personality disorders in community settings: A 






































Personality Disorders (PDs) are increasingly recognised as a mental health priority area in many 
countries. Nevertheless, there are no systematic reviews examining the global prevalence of PDs, 
and whether rates differ in high and low and middle-income countries (LAMICs).    
Method 
We searched PsycINFO, MEDLINE, EMBASE, and PubMed databases from January 1980 to May 
2018. Two authors independently screened abstracts and full text articles. Studies were quality 
assessed with the Joanna Briggs Institute Critical Appraisal Tool. We used meta-analysis to estimate 
pooled prevalence rates, and meta-regression to estimate the effects of study methodology on 
estimate variability.  
Results  
We identified 31 community studies from 21 different countries. Twenty-five studies were included 
in the final analysis. The worldwide pooled prevalence of any PD was 7.5 % (95% Confidence 
Intervals: 5.6, 9.5), with greater rates in high (9.2%; 95% CI: 7.0, 10.8%) compared to LAMI (4.1%; 
95% CI =2.7, 5.5%) countries. There was significant heterogeneity across pooled estimates. Study 
design and study country remained significant moderators of estimates in the multiple meta-
regression model. Prevalence rates of Cluster-A PDs were very similar in high and LAMI countries 
(3.5% vs 3.7%), while rates of Cluster B (3.5% vs 1.6%) and C PDs (6.6% vs 3.4%) were greater in 
high income countries.   
Conclusions  
Our meta-analysis indicates that PDs are prevalent globally and affect people across most regions of 





health strategies are needed to address the unmet needs of individuals with PDs, particularly in 


























Before the 1960s, personality disorder (PD) was viewed as an unreliable diagnosis of limited clinical 
utility. PDs (including Clusters A, B and C) are now recognised as important conditions, which are 
associated with morbidity, premature mortality, and great costs to society (Tyrer, Mulder et al. 2010, 
Moran, Romaniuk et al. 2016).  
A recent narrative review reported relatively high rates of PDs (4.4% - 21.5%) in community 
populations across England, Wales, Scotland, Western Europe, Norway, Australia, and the US 
(Quirk, Berk et al. 2016). To the best of our knowledge, however, there are no reviews examining 
global prevalence of PDs, and whether rates vary between high and low-and middle-income (LAMI) 
countries.  
 These questions are important for several reasons. First, over 80% of the global population 
live in LAMICs, and mental health is now recognised as a public health priority in these areas (Patel 
2007). Nevertheless, personality disorders are not included within the scope of policy-informing 
initiatives, such as the WHO Mental Health Gap Action Programme (Bruckner, Scheffler et al. 
2011) and the Global Burden of Diseases Project (Quirk, Williams et al. 2015). Second, PDs are 
often under-recognised in clinical practice, particularly in LAMICs where stigma and 
misunderstanding surrounds the diagnosis (Tyrer, Reed et al. 2015, Santana, Coelho et al. 2018).  
Third, it is unclear whether (and how) diagnostic tools and treatment modalities need to be culturally 
tailored for LAMICs (Ryder, Sunohara et al. 2015, Ronningstam, Keng et al. 2018). Finally, 
personality disorders are characterised by high levels of mental, physical, and functional impairment 
(Winsper, Marwaha et al. 2015, Moran, Romaniuk et al. 2016). Neglecting their effects at the 







The current review addresses the following research questions:  
• What is the global pooled prevalence of any PD, and Clusters A, B, and C PD in community 
settings? 
• Do pooled prevalence rates differ between high and LAMI countries?  
• Do methodological factors (population characteristics, sample characteristics, study 





We used PRISMA (Moher, Shamseer et al. 2015) guidelines as a framework. The protocol was 
registered with PROSPERO prior to conducting searches and updated before data extraction 
(registration number: CRD42017065094).  
 
Search strategy 
We searched PsycINFO, MEDLINE, EMBASE, and PubMed from January 1980 to May 2017 for 
articles published in any language. We updated the search on the 24th May 2018. We combined the 
following three search strings: (Personality disorder* OR Axis-II) AND (Prevalen* OR rate* OR 
frequency OR percentage) AND (epidemiolog* OR communit* OR general population OR 
population OR student* OR healthy sample OR normal population OR representative sample*). We 
inspected the reference lists of retrieved articles and cross-referenced our findings against published 





independently screened 100% of the abstracts for full text retrieval, and 100% of the full text articles 
for inclusion in the review.  
Inclusion criteria 
1. The study provided a prevalence figure for any PD or a Cluster A, B, or C PD; 
2. Participants were adolescents or adults (≥mean age 12 years) from a community (or school) 
population; 
3. Studies used interviews or self-report questionnaires. We included self-report questionnaires in the 
first instance to examine impact on prevalence estimates (Oltmanns, Rodrigues et al. 2014); 
4. Studies published in any language; 
5. Studies published in peer-reviewed journals. 
Exclusion criteria 
1. Studies in clinical, medical, psychiatric, or prison settings; 
2. Studies with biased samples (e.g., chronic pain groups); 
3. Case control studies as they involve strongly selected samples (Simon, Czobor et al. 2009);  
4. Studies with less than 100 participants (Van Os, Linscott et al. 2009);  
5. Studies with diagnoses based on clinical records/administrative databases (Polanczyk, De Lima et 
al. 2007);  
6. Reviews; 
7. Studies below the quality assessment threshold (< 4 points) 
 
Data extraction and quality assessment  
We developed a data extraction form to record: prevalence rates and standard errors (or data to 
calculate these figures); year of study; country of study (and World Bank classification); sample: 





estimation approach; assessment method; evaluation instrument, e.g., SCID-II; and diagnostic 
criteria. e.g., DSM-IV.  
Full text articles adhering to the inclusion criteria were quality assessed by CW. We used an 
adapted version of the Joanna Briggs Institute Critical Appraisal Tool for prevalence reviews (Munn, 
Moola et al. 2014). Each study was rated on eight categories: 1) representativeness of target 
population; 2) recruitment of participants; 3) sample size; 4) description of study subjects and 
setting; 5) coverage of identified sample; 6) objectivity of assessment; 7) reliability of the assessment; 
and 8) appropriate statistical analysis. We calculated a quality score for each study ranging from 0 to 
8. Studies scoring 4 or above were included in the final review.  
 
Data analysis  
Meta-analysis  
We used STATA version 14. Pooled prevalence was computed across studies using the metan 
command. A random effects model was chosen as we were using real-world data, which is expected 
to have variable population parameters (Winsper, Ganapathy et al. 2013). We assessed heterogeneity 
across studies with the I2 statistic (reported with a p value). We pooled prevalence rates of any 
personality disorder (PD). ‘Any PD’ referred to the presence of one or more categorical PD as 
defined in each of the studies. We then pooled the prevalence of three PD clusters. Cluster A 
includes any categorical paranoid, schizotypal, or schizoid PD. Cluster B includes any categorical 
histrionic, borderline, narcissistic or antisocial PD. Cluster C includes any categorical avoidant, 
dependent or obsessive compulsive PD (American Psychiatric Association 2013).  
Sensitivity analysis 
We conducted sensitivity analysis to evaluate the influence of each study on pooled prevalence using 





questionnaires inflated PD prevalence figures (Dereboy, Güzel et al. 2014, Oltmanns, Rodrigues et 
al. 2014) by comparing pooled rates between self-report questionnaire and interview studies.     
Sub-analyses and meta-regression analysis  
We used sub-analysis and meta-regressions to examine the impact of study characteristics on PD 
prevalence estimates. We selected study factors a priori based on previous reviews on mental health 
prevalence (Steel, Marnane et al. 2014, Polanczyk, Salum et al. 2015) and the assessment of PDs 
specifically (Banerjee, Gibbon et al. 2009, Beckwith, Moran et al. 2014, Tyrer, Reed et al. 2015).   
We considered the following factors:  
Population characteristics  
1. Country of study - broad (1= high income; 2= LAMI)  
2. Country of study – breakdown (1=Asia; 2 = other LAMICs; 3=Europe; 4=North America; 
5=Australia). We separated Asian studies from other LAMIC studies, as we anticipated lower rates 
in these countries (Steel, Marnane et al. 2014, Ronningstam, Keng et al. 2018). 
2. Study year (1 = before 2000; 2 = 2000-2009; 3 = 2010 onwards) 
Sample characteristics  
1. Sample size (1= <1000; 2= 1000-4999; 3= 5000-9999; 4 =10 000+) 
Study methods  
1. Sampling (1=country or large city/area weighted to represent population; 2=medium or small 
city/area with complex sampling to improve representativeness; 3=small area/sample with no 
complex sampling approach).  
2. Study design (1=one-step assessment; 2= two-step assessment) 
Assessment methods  
1. Diagnostic criteria (1=ICD 8/9/10; 2=DSM-III/R; 3=DSM-IV) 





3. Study instruments (1=clinical interview; 2=SCID-II; 3=IPDE; 4=SIDP-IV/R; 5=other, i.e., 
assessment only used in one study).  
We conducted univariate meta-regressions for each factor. Covariates associated with heterogeneity 
at the p<0.05 level were included in the multivariate analysis.  
 
Results  
Of the original 3879 abstracts, 533 articles were selected for full text review. There was an acceptable 
level of agreement between raters (Kappa = 0.80). The updated search yielded a further 458 abstracts, 
of which 20 full text articles were retrieved for inspection. Three articles were identified by hand 
search. In total there were 556 full text articles. Of the full text articles, 55 fulfilled our initial 
inclusion criteria (prior to the quality assessment). Inter-rater reliability was acceptable (Kappa = 
0.82). The authors discussed discrepancies at the abstract and full text stage, most of which related 
to duplicate data and whether the study sample was biased (Figure 1).  
 
Description of studies  
Thirty-one studies from twenty-one different countries reached our quality assessment threshold. 
See Table 1 for an overview, including sample description, sampling frame, and diagnostic 
approach. One study from the WHO World Mental Health Surveys (Huang, Kotov et al. 2009) 
provided eight independent prevalence estimates. Most studies were published in English language, 
excepting one German (Barnow, Stopsack et al. 2010), one Icelandic (Lindal and Stefansson 2009) 
and four Chinese (Huang, Liu et al. 2002, Fu, Yao et al. 2008, Qi, Xu et al. 2009, Liu and Ning 2010) 
articles. CW extracted data from the German and Icelandic publications using Google Translate. A.W 






Quality assessment of included studies 
Please refer to Supplementary Table 1 for an overview of the quality assessment. Lower scores 
indicate higher chance of bias in prevalence estimates (Munn, Moola et al. 2014) rather than study 
quality per se. Eleven studies scored between 4 and 4.5 out of 8; sixteen scored between 5 and 6 out 
of 8; and four scored 7 out of 8. Generally, self-report questionnaire studies, e.g. , Lindal and 
Stefansson (2009) and those with less robust recruitment strategies, e.g., Maier, Lichtermann et al. 
(1992) yielded the lowest scores.  
 
Sensitivity analysis 
We included twenty-eight studies (35 individual prevalence estimates) in the initial meta-analysis of 
any PD. Inspection of the funnel plot highlighted one study (Hickling and Walcott 2013) as an 
outlier. Sensitivity analysis (Supplementary Table 2) confirmed that removing this study had a 
relatively substantive effect on the overall pooled prevalence, thus we excluded from further 
analysis.  The five self-report questionnaire studies (11.2%; 95% CI: 2.8, 19.6%) yielded markedly 
higher pooled prevalence rates than the twenty-five interview studies (7.5%; 95% CI: 5.6, 9.5%) and 
were thus excluded from the final analysis. This left twenty-two studies providing twenty-nine 
prevalence estimates for the meta-analysis of any PD. Eleven of these studies also reported on a 
Cluster A, B or C PD. One reported on just Cluster B PD (Fu, Yao et al. 2008), and one on just 
Cluster C PD (Liu and Ning 2010).   
 
Pooled prevalence of any personality disorder 
The global pooled prevalence of any PD was 7.5% (95% CIs: 5.6-9.5). There was substantial 
heterogeneity among estimates (I2 = 99.7%, p< .001). We thus conducted our pre-planned analysis of 





Sub-analyses and univariate meta-regressions according to methodological factors  
See Table 2 for results of the sub-analyses and univariate meta-regressions. Pooled prevalence rates 
were significantly greater in high income compared to LAMI countries (according to both broad and 
finer-grained categories: Figure 2). LAMICs predicted significantly lower pooled prevalence rates 
than high income countries accounting for 18.9% of between study variance. Asian studies predicted 
significantly lower pooled prevalence rates than European, North American and Australian studies, 
accounting for 38.4% of between study variance. Two-stage assessments yielded significantly lower 




In the multiple meta-regression analysis, study design and country (Asia vs Australia only) remained 
significant predictors of heterogeneity (study design: β = -.042, p = .046; study country: β = .085, 
p=.022). The broader distinction between high and LAMI countries did not remain a significant 
predictor of heterogeneity in the multiple metaregression analysis (β = -.012, p=0.60). This final 
model accounted for just under half of the heterogeneity in prevalence rates across studies (Adjusted 
R-squared: 46.3%).  
 
Prevalence of Cluster A, B and C PDs 
See Figure 3 for an overview of Cluster A, B and C PD prevalence rates by country classification.  
Twelve studies (19 estimates) examined Cluster-A prevalence (pooled prevalence: 3.6 %; 95% CIs: 
2.9, 4.2; I2 =91.0%). Two studies (7 estimates) reported prevalence rates in LAMI countries (3.7%; 
95% CI =2.6, 4.8%; I2 =78.4%) and eleven (12 estimates) in high income countries (pooled 





Twelve studies (19 estimates) reported Cluster B prevalence (2.7%; 95% CIs: 1.6, 3.7; I2 =98.3%). 
Three studies (8 estimates) reported prevalence rates in LAMI countries (1.5%; 95% CI =1.0, 2.0%; 
I2 =80.8%) and eleven (12 estimates) in high income countries (pooled prevalence 3.5%; 95% CI: 
2.1, 4.9%; I2 =98.3%).  
Twelve studies (19 estimates) reported Cluster C prevalence (5.2%; 95% CIs: 3.9, 6.6; I2 
=98.0%). Three studies (8 estimates) reported prevalence rates in LAMI countries (3.4%; 95% CI 
=1.9, 4.9%; I2 =93.6%) and ten (11 estimates) in high income countries (pooled prevalence 6.6%; 




We identified thirty-one community studies assessing the prevalence of any PD (or Cluster A, B, or 
C-PD) from twenty-one different countries. Twenty-two of these studies were included in the final 
meta-analysis for any PD, and twelve for the meta-analyses of Cluster A, B and C-PDs respectively. 
The global pooled prevalence of any PD was 7.5% (95% CI: 5.6-9.5). We found significant 
heterogeneity across studies, which was partly explained by study design (two-stage vs one-stage 
assessment) and study country (Asian vs Australian studies).  
To the best of our knowledge this is the first worldwide-pooled prevalence estimate of PDs 
in the community, and exceeds global period prevalence rates of mood (5.4%) and anxiety (6.7%) 
disorders (Steel, Marnane et al. 2014). The pooled prevalence of any PD was considerably lower in 
LAMI (4.1%) than high income (9.2%) countries. Similarly, Cluster B (3.5% vs 1.5%) and C (6.6% vs 






First, there may exist a lower population risk in LAMICs due to key cultural or other protective 
factors (Cheng, Huang et al. 2010, Steel, Marnane et al. 2014, Gawda and Czubak 2017). Sub-
analysis showed that LAMI Asian countries had the lowest pooled prevalence (2.0%), which mirrors 
previous findings of lower rates in Asia for depression and anxiety (Ferrari, Somerville et al. 2013, 
Steel, Marnane et al. 2014). In relation to PDs specifically, core problems such as emotion 
dysregulation and interpersonal dysfunction may be less likely within cultural contexts emphasising 
collectivism and conformity. Indeed, the diagnosis of borderline personality disorder is often met 
with skepticism in China due to a perceived mismatch between core symptoms and cultural setting 
(Ronningstam, Keng et al. 2018). Second, current diagnostic tools and criteria may underestimate the 
prevalence of PDs in LAMICs (Steel, Silove et al. 2009). Two Asian studies conducted by Western 
psychiatrists reported strikingly low PD prevalence rates in China (Cheung 1991) and Bangladesh 
(Hosain, Chatterjee et al. 2007). In contrast, the WHO mental health survey reported a prevalence of 
4.1% in China when using the cross-cultural International Personality Disorder Examination tool 
(World Health Organization 1997, Huang, Kotov et al. 2009). Other LAMI countries (also from the 
WHO survey) had a pooled prevalence of 6.0%, which is largely comparable to the pooled estimate 
for Europe. While the use of uniform (cross-cultural) assessment tools may improve inter-country 
comparisons, researchers should also consider cultural nuances in symptom clusters, which could 
moderate aetiology and illness presentation (Soh and Keng 2018). Third, differences in pooled 
prevalence could be partly attributable to methodological confounders. Study design was a strong 
predictor of heterogeneity in both univariate and multiple meta-regression analysis, while high versus 
LAMI country became a non-significant predictor in the final multivariate model. Thus, study design 
may have confounded the effect of study country on prevalence estimate (i.e., all one-step studies 
were from high income countries potentially inflating the gap between high and LAMI countries).  





The relatively high global prevalence of Cluster-A PDs contrasts with low presentation of these 
disorders in clinical settings (Soeteman, Roijen et al. 2008). These three PDs (paranoid, schizoid and 
schizotypal) often receive the least research attention (Bateman, Gunderson et al. 2015) despite 
being associated with chronic physical comorbidities including cardiovascular disease and arthritis 
(Quirk, Berk et al. 2016).    
We found that the pooled prevalence of any PD was especially high in Australia (15.6%). 
This finding should be interpreted with caution, due to the paucity of studies and wide variability in 
prevalence estimates across studies. Quirk, Berk et al. (2017) found a prevalence of 21.8% in an age-
stratified female cohort originally established to describe the epidemiology of osteoporosis. Moran, 
Coffey et al. (2006) reported a prevalence of 18.6% (according to informant report) in a nationally 
representative longitudinal cohort of young people. Jackson and Burgess (2000) found a more 
conservative prevalence of 6.5% in the Australian National Survey of Mental Health and Wellbeing. 
As personality disorders are increasingly recognised as a mental health priority in Australia, we 
anticipate the collection of more representative data (Chanen, Sharp et al. 2017, Grenyer, Ng et al. 
2017).  
 
Methodological considerations and limitations 
 
There are several limitations that should be noted when considering our review findings. First, we 
identified substantial inter-study heterogeneity across all models with high and significant I2 values. 
Pooled prevalence estimates were similarly heterogeneous in previous reviews on ADHD 
(Polanczyk, De Lima et al. 2007) and common mental disorders (Steel, Marnane et al. 2014, 
Polanczyk, Salum et al. 2015). Heterogeneity can affect the stability and interpretability of pooled 
prevalence estimates (Steel, Marnane et al. 2014). However, I2 may be artificially inflated when 





variation (Higgins 2008, Coory 2009). Second, only two of our a priori selected covariates had a 
significant impact on variability of estimates. Other factors, such as diagnostic assessment, had an 
impact on pooled prevalence in the sub-analysis, but were not significant predictors in the meta-
regression. Although we conducted a comprehensive search, we were only able to identify a 
relatively small number of epidemiological studies highlighting the lack of research in this area. This 
could have limited our power to detect significant moderators, and fully disentangle the confounding 
effects of inter-related moderators (Lipsey 2003). Third, there were some potential moderating 
factors we could not include in our analysis due to insufficient data, or a difficulty in constructing 
meaningful categories. Factors such as age, sex, urbanicity, and socioeconomic status, for example, 
could have an impact on PD prevalence rates (Torgersen, Kringlen et al. 2001, Huang, Kotov et al. 
2009). Fourth, because of the limited number of studies, we had to construct relatively crude 
categories for some moderators. For example, ‘LAMICs’ covered a wide variety of countries (both 
low-middle and high-middle) and included megacities (Santana, Coelho et al. 2018) and rural areas 
(Hosain, Chatterjee et al. 2007), which varied widely in prevalence rates. Finally, we only pooled 
categorical PD prevalence figures. The assumption that PDs are categorical is highly contested. 
Nevertheless, the DSM-5 has retained the ten discrete PDs (Ryder, Sunohara et al. 2015) and 
personality disorder can be described as a unitary construct (Quirk, Berk et al. 2016). Future 
epidemiological studies should use both categorical and dimensional measures in anticipation of 
potential changes to diagnostic systems (Hopwood, Kotov et al. 2018).   
 
Conclusions 
Epidemiological research on personality disorders is relatively sparse, with a particular paucity of 
data from less developed regions (Santana, Coelho et al. 2018). Pooled rates of PDs (except Cluster 





to methodological artefacts remains unclear. Future studies should further investigate potential 
sources of divergence using culturally secure assessment techniques (Balaratnasingam and Janca 
2017). Narrative based assessments and visual aids may be more appropriate than symptom 
checklists for non-Western cultures (Balaratnasingam, Anderson et al. 2015), and could help 
community mental health workers identify PDs in areas where psychiatrists are unavailable 
(Agyapong, Osei et al. 2015).  
PDs are common across many areas of the world and should be recognised as an important 
contributor to population mental health and disease burden (Tyrer, Mulder et al. 2010, Quirk, Berk 
et al. 2016). Personality pathology continues to be overlooked in clinical practice (Newton-Howes, 
Clark et al. 2015) particularly in LAMICs where resources are limited (Agyapong, Osei et al. 2015) 
and PDs are surrounded by misunderstanding and stigma (Huang, Kotov et al. 2009, Santana, 
Coelho et al. 2018). Though PDs are now considered treatable (Chanen, Sharp et al. 2017) the 
evidence base is underdeveloped with an over emphasis on borderline personality disorder 
(Bateman, Gunderson et al. 2015). Moving forward, we need more accurate and representative data 
to underpin the development of mental health care reform, including an emphasis on early 
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